Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1359 ARTÍCULOS , VIENDO DEL 61 AL 75

Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients

Rostomian AH, Madison C, Rabinovici GD, Jagust WJ.

J Nucl Med. 2011 Feb;52(2):173-9. doi: 10.2967/jnumed.110.082057. Epub 2011 Jan 13.

Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: a missing link to therapeutic potential

Sato N, Takeda S, Uchio-Yamada K, Ueda H, Fujisawa T, Rakugi H, Morishita R.

Curr Aging Sci. 2011 Jul;4(2):118-27. doi: 10.2174/1874609811104020118.

Simvastatin and other HMG-CoA reductase inhibitors on brain cholesterol levels in Alzheimer's disease

Longenberger J, Shah ZA.

Curr Alzheimer Res. 2011 Jun;8(4):434-42. doi: 10.2174/156720511795745393.

Mitochondria: the common upstream driver of amyloid-β and tau pathology in Alzheimer's disease

Silva DF, Esteves AR, Oliveira CR, Cardoso SM.

Curr Alzheimer Res. 2011 Aug;8(5):563-72. doi: 10.2174/156720511796391872.

Low-n oligomers as therapeutic targets of Alzheimer's disease

Ono K, Yamada M.

J Neurochem. 2011 Apr;117(1):19-28. doi: 10.1111/j.1471-4159.2011.07187.x. Epub 2011 Feb 9.

Use of florbetapir-PET for imaging beta-amyloid pathology

Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, Pontecorvo MJ, Hefti F, Carpenter AP, Flitter ML, Krautkramer MJ, Kung HF, Coleman RE, Doraiswamy PM, Fleisher AS, Sabbagh MN, Sadowsky CH, Reiman EP, Zehntner SP, Skovronsky DM; AV45-A07 Study Group.

JAMA. 2011 Jan 19;305(3):275-83. doi: 10.1001/jama.2010.2008.

Applause sign: is it really specific for Parkinsonian disorders? Evidence from cortical dementias

Luzzi S, Fabi K, Pesallaccia M, Silvestrini M, Provinciali L.

J Neurol Neurosurg Psychiatry. 2011 Aug;82(8):830-3. doi: 10.1136/jnnp.2010.224394. Epub 2011 Jan 18.

The role of G protein-coupled receptors in the pathology of Alzheimer's disease

Thathiah A, De Strooper B.

Nat Rev Neurosci. 2011 Feb;12(2):73-87. doi: 10.1038/nrn2977.

Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer's disease and the brain of aged dogs with cognitive dysfunction

Yu CH, Song GS, Yhee JY, Kim JH, Im KS, Nho WG, Lee JH, Sur JH.

J Comp Pathol. 2011 Jul;145(1):45-58. doi: 10.1016/j.jcpa.2010.11.004. Epub 2011 Jan 21.

Neuroprotective therapeutics for Alzheimer's disease: progress and prospects

Palmer AM.

Trends Pharmacol Sci. 2011 Mar;32(3):141-7. doi: 10.1016/j.tips.2010.12.007. Epub 2011 Jan 20.

Antibody-based therapy in Alzheimer's disease

Pul R, Dodel R, Stangel M.

Expert Opin Biol Ther. 2011 Mar;11(3):343-57. doi: 10.1517/14712598.2011.552884. Epub 2011 Jan 25.

Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA.

Ageing Res Rev. 2011 Apr;10(2):264-73. doi: 10.1016/j.arr.2011.01.001. Epub 2011 Jan 22.

Neuropathology and amyloid-β spectrum in a bapineuzumab immunotherapy recipient

Roher AE, Maarouf CL, Daugs ID, Kokjohn TA, Hunter JM, Sabbagh MN, Beach TG.

J Alzheimers Dis. 2011;24(2):315-25. doi: 10.3233/JAD-2011-101809.

Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease

Perrin RJ, Craig-Schapiro R, Malone JP, Shah AR, Gilmore P, Davis AE, Roe CM, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, Kaye JA, Morris JC, Holtzman DM, Townsend RR, Fagan AM.

PLoS One. 2011 Jan 12;6(1):e16032. doi: 10.1371/journal.pone.0016032.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias